Featured Abstracts
Review key findings and research highlights presented at major industry conferences and events.
Featured Content
ASTRO 2025
Stereotactic Radiotherapy Boost in Locally Advanced Cervical Carcinoma Patients (STARBACS): Up-to-Date Results of a Phase II, Single Arm, Monoinstitutional Study
ASTRO 2025
Evaluation of Necessary and Sufficient PTV Margins for Offline Adaptive Head and Neck Cases Treated with TomoTherapy
ASTRO 2025
Stereotactic Body Radiation Therapy to Only Prostate and Proximal Seminal Vesicles is a Viable Option for a Favorable Subset of High-Risk Prostate Cancer Patients
Featured Case Studies
Robotic Stereotactic Body Radiation Therapy For High-risk Prostate Cancer: The Georgetown University Experience
This retrospective study examines cancer control and health-related quality of life (HRQOL) outcomes in high-risk prostate cancer patients receiving robotic stereotactic body radiation therapy (SBRT) with Synchrony® real-time adaptive motion management.
Use of Motion Management to Model Unmanaged Motion: Dosimetric Consequences of Unmanaged Prostate Motion Assessed Using Real-time Radiotherapy Adaptation Data
This case report explores the dosimetric impact of unmanaged intrafraction prostate motion during radiotherapy by retrospectively analyzing real-time motion data collected using the Radixact® System with Synchrony®. The study models what would have happened if a patient had been treated without motion management, using deformation vector fields to simulate dose
Stereotactic Body Radiotherapy of a Lung Tumor with Large Respiratory Motion Using Real-time Adaptive Motion Management: A Case Report
Traditional internal target volume (ITV) methods for the treatment of a lung tumor on conventional linac would require a large planning target volume (PTV), risking high radiation exposure to the chest wall and lungs.
Clinical Assessment of Potential Difference in Motion-Tracking Irradiation for Liver Tumors Using Radixact Synchrony®
Okada W, Doi H, Sano K, Muraoka R, Anami S, Shintani T, Tanooka M. | Cureus Competition | 2025
Real-Time Adaptive Motion Management in Prostate Stereotactic Body Radiation Therapy: Clinical and Dosimetric Analysis of 25 Patients
Goddard LC, Cabrera J, Tang J, Garg MK, Tome WA. | Cureus Competition | 2025
A System for Verifying Radiation Therapy Treatments That Use Multiple Modes of Real-Time Motion Adaptation.
Kairn T, Yu L, Crowe SB. | Cureus Competition | 2025
Use of Motion Management to Model Unmanaged Motion: Dosimetric Consequences of Unmanaged Prostate Motion Assessed Using Real-Time Radiotherapy Adaptation Data
Crowe SB, Walsh J, Rattray G, Chan P, Kairn T. | Cureus Competition | 2025
Real-Time Motion Management for a Small Target in the Right Lower Lobe With Large Tumor Motion Using Radixact Synchrony: A Case Report
Guang-Pei Chen, An Tai, Lindsay Puckett, Eric Paulson. | Cureus Competition | 2025
Real-Time Adaptive Respiratory Motion Compensation With Stent-Based Tracking
Goddard L C, Rhieu B, Tomé W A. | Cureus Competition | 2025
The Early Experience of Synchrony in Ultra-Hypofractionation for Prostate Cancer: A Case Series
Toapichattrakul P, Muangwong P, Kongsa A, et al. | Cureus Competition | 2025
Real-Time Adaptive Motion Management Using CyberKnife Synchrony™ for Lung Stereotactic Body Radiotherapy (SBRT): A Case Report
Gao J, Zhang S, Han J, Yang J. | Cureus Competition | 2025
3604: Artificial Intelligence-driven Failure Prediction on TomoTherapy® Systems
Kélian Poujade et al. | ESTRO | 2025
4368: Dosimetric Parameters in Total Marrow and Lymphoid Irradiation and Risk of Acute Graft-Versus-Host Disease
Simonetta Saldi et al. | ESTRO | 2025
2849: Bladder Preservation Using Immunotherapy and Radiotherapy in Muscle-Invasive Bladder Cancer
Isabela Gaztelu et al. | ESTRO | 2025
3607: Stereotactic Body Radiotherapy (SBRT) for Non Surgical Cholangiocarcinoma
Jesús Romero Fernandez et al. | ESTRO | 2025
3640: TomoTherapy for In-transit or Metastatic Lower Limb Melanoma
Joaquín Velasco-Jiménez et al. | ESTRO | 2025
3062: Definitive TomoTherapy-based Radiotherapy Facial Lentigo Maligna. The Experience of Centro di Riferimento Oncologico di Aviano CRO-IRCCS
Giuseppe Fanetti et al. | ESTRO | 2025
